AEGON Asset Management (UK)’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-604,393
Closed -$4.29M 183
2022
Q1
$4.29M Buy
604,393
+19,802
+3% +$164K 0.06% 117
2021
Q4
$10.6M Buy
584,591
+315,266
+117% +$6.8M 0.14% 113
2021
Q3
$5.27M Buy
269,325
+146,095
+119% +$5.56M 0.07% 120
2021
Q2
$5.52M Buy
123,230
+30,612
+33% +$1.42M 0.08% 124
2021
Q1
$4.64M Buy
+92,618
New +$6.31M 0.07% 122

Other funds holding CELL

AEGON Asset Management (UK)'s CELL Position: Q2 2022 in Review

AEGON Asset Management (UK) sold out of PhenomeX Inc. Common Stock (CELL) in Q2 2022, closing a stake of 604,393 shares — an estimated $4.29M sold.

AEGON Asset Management (UK) first reported a position in CELL in Q1 2021 and held it in 5 quarters. The position peaked at $10.6M in Q4 2021. 123 funds tracked by Wall St. Rank hold CELL as of Q2 2022.

  • AEGON Asset Management (UK) reported no remaining PhenomeX Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • AEGON Asset Management (UK) sold 604,393 PhenomeX Inc. Common Stock shares in Q2 2022, an estimated $4.29M.
  • AEGON Asset Management (UK) first reported a position in PhenomeX Inc. Common Stock in Q1 2021 and held it in 5 quarters.
  • AEGON Asset Management (UK)'s PhenomeX Inc. Common Stock position peaked at $10.6M in Q4 2021.
  • 123 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q2 2022.

Based on AEGON Asset Management (UK)'s 13F filing for Q2 2022, filed 12 Jul 2022.